Internal transcribed spacer region sequence analysis using SmartGene IDNS software for the identification of unusual clinical yeast isolates

References

• Garey KW, Rege M, Pai MP, . Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006; 43: 25–31.
   PubMed Web of Science ®Google Scholar
• Cendejas-Bueno E, Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M. Identification of pathogenic rare yeast species in clinical samples: comparison between phenotypical and molecular methods. J Clin Microbiol 2010; 48: 1895–1899.
   PubMed Web of Science ®Google Scholar
• Ciardo DE, Schar G, Bottger EC, Altwegg M, Bosshard PP. Internal transcribed spacer sequencing versus biochemical profiling for identification of medically important yeasts. J Clin Microbiol 2006; 44: 77–84.
   PubMed Web of Science ®Google Scholar
• Sanguinetti M, Porta R, Sali M, . Evaluation of Vitek 2 and rapid yeast plus systems for yeast species identification: experience at a large clinical microbiology laboratory. J Clin Microbiol 2007; 45: 1343–1346.
   PubMed Web of Science ®Google Scholar
• White PL, Archer AE, Barnes RA. Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections. J Clin Microbiol 2005; 43: 2181–2187.
   PubMed Web of Science ®Google Scholar
• Chen YC, Eisner JD, Kattar MM, . Polymorphic Internal Transcribed Spacer region 1 DNA sequences identify medically important yeasts. J Clin Microbiol 2001; 39: 4042–4051.
   PubMed Web of Science ®Google Scholar
• Ferrer C, Colom F, Frases S, . Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8s ribosomal DNA typing in ocular infections. J Clin Microbiol 2001; 39: 2873–2879.
   PubMed Web of Science ®Google Scholar
• Gaitanis G, Robert V, Velegraki A. Verifiable single nucleotide polymorphisms of the Internal Transcribed Spacer 2 region for the identification of 11 Malassezia species. J Dermatol Sci 2006; 43: 214–217.
   PubMed Web of Science ®Google Scholar
• Leaw SN, Chang HC, Sun HF, . Identification of medically important yeast species by sequence analysis of the Internal Transcribed Spacer regions. J Clin Microbiol 2006; 44: 693–699.
   PubMed Web of Science ®Google Scholar
• Linton CJ, Borman AM, Cheung G, . Molecular identification of unusual pathogenic yeast isolates by large ribosomal subunit gene sequencing: 2 years of experience at the United Kingdom mycology reference laboratory. J Clin Microbiol 2007; 45: 1152–1158.
   PubMed Web of Science ®Google Scholar
• Putignani L, Paglia MG, Bordi E, . Identification of clinically relevant yeast species by DNA sequence analysis of the D2 variable region of the 25-28s rRNA gene. Mycoses 2008; 51: 209–227.
   PubMed Web of Science ®Google Scholar
• Villa-Carvajal M, Querol A, Belloch C. Identification of species in the genus Pichia by restriction of the Internal Transcribed Spacers (ITS1 and ITS2) and the 5.8s ribosomal DNA gene. Antonie Van Leeuwenhoek 2006; 90: 171–181.
   PubMed Web of Science ®Google Scholar
• Hall L, Wohlfiel S, Roberts GD. Experience with the Microseq D2 large-subunit ribosomal DNA sequencing kit for identification of commonly encountered, clinically important yeast species. J Clin Microbiol 2003; 41: 5099–5102.
   PubMed Web of Science ®Google Scholar
• Qian Q, Tang YW, Kolbert CP, . Direct identification of bacteria from positive blood cultures by amplification and sequencing of the 16s rRNA gene: evaluation of BACTEC 9240 instrument true-positive and false-positive results. J Clin Microbiol 2001; 39: 3578–3582.
   PubMed Web of Science ®Google Scholar
• Simmon KE, Croft AC, Petti CA. Application of SmartGene IDNS software to partial 16s rRNA gene sequences for a diverse group of bacteria in a clinical laboratory. J Clin Microbiol 2006; 44: 4400–4406.
   PubMed Web of Science ®Google Scholar
• Clinical Laboratory Standards Institute. Interpertive Criteria for Identification of Bacteria and Fungi by DNA Target Sequencing, approved guideline, document MM18-A. Wayne, PA: Clinical Laboratory Standards Institute; 2008.
   Google Scholar
• Pfaller MA, Jones RN, Doern GV, . Bloodstream infections due to Candida species: sentry antimicrobial surveillance program in North America and Latin America, 1997–1998. Antimicrob Agents Chemother 2000; 44: 747–751.
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Messer SA, Boyken LB, . In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods. J Clin Microbiol 2009; 47: 3170–3177.
   PubMed Web of Science ®Google Scholar
• Lockhart SR, Messer SA, Gherna M, . Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature. J Clin Microbiol 2009; 47: 1216–1217.
   PubMed Web of Science ®Google Scholar
• Sullivan DJ, Moran GP, Pinjon E, . Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 2004; 4: 369–376.
   PubMed Web of Science ®Google Scholar
• Bader O, Weig M, Taverne-Ghadwal L, . Improved clinical laboratory identification of human pathogenic yeasts by Matrix-Assisted Laser Desorption Ionization Time-of-Flight mass spectrometry. Clin Microbiol Infect 2011; 21: 1359–1365.
   Google Scholar
• Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL. Performance and cost analysis of Matrix-Assisted Laser Desorption Ionization-Time of Flight mass spectrometry for routine identification of yeast. J Clin Microbiol 2011; 49: 1614–1616.
   PubMed Web of Science ®Google Scholar
• Diaz MR, Boekhout T, Kiesling T, Fell JW. Comparative analysis of the Intergenic Spacer regions and population structure of the species complex of the pathogenic yeast Cryptococcus neoformans. FEMS Yeast Res 2005; 5: 1129–1140.
   PubMed Web of Science ®Google Scholar
• Sugita T, Nakajima M, Ikeda R, Matsushima T, Shinoda T. Sequence analysis of the ribosomal DNA Intergenic Spacer 1 regions of Trichosporon species. J Clin Microbiol 2002; 40: 1826–1830.
   PubMed Web of Science ®Google Scholar
• Atkinson BJ, Lewis RE, Kontoyiannis DP. Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. Med Mycol 2008; 46: 541–546.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Boyken L, Hollis RJ, . Wild-type mic distributions and epidemiological cutoff values for the echinocandins and Candida spp. J Clin Microbiol 2010; 48: 52–56.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Mendez M, . Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the artemis disk antifungal surveillance program. J Clin Microbiol 2006; 44: 3551–3556.
   PubMed Web of Science ®Google Scholar
• Kim MN, Shin JH, Sung H, . Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis 2009; 48: e57–61.
   PubMed Web of Science ®Google Scholar
• Borman AM, Petch R, Linton CJ, . Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents. J Clin Microbiol 2008; 46: 933–938.
   PubMed Web of Science ®Google Scholar
• Jensen RH, Arendrup MC. Candida palmioleophila: characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species. J Clin Microbiol 2011; 49: 549–556.
   PubMed Web of Science ®Google Scholar